Austar Lifesciences Announces 2022 Annual Results

Published by
ACN Newswire

Benefiting from Effective Management of Supply Chain and Project Execution in the Business Segment of Liquid and Bioprocess System, the Group Recorded a Growth of Over 10%; To Seize the Rapid Development Opportunities of Cell and Gene Therapy Sector and to Enlarge Business Potential in the Future HONG KONG, Mar 31, 2023 – (ACN Newswire) – Austar Lifesciences Limited (AUSTAR or Company) (HKEX Stock Code: 6118.HK), a technology-based pharmaceutical engineering solution provider, together with its subsidiaries (collectively the Group or AUSTAR Group), announced its audited annual results for the …

Read More

See also  CT Event Asia to host ASEAN Healthcare Transformation Summit 2022

Leave a Reply